Position in XBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$341,750
-$26,589 QoQ
Shares Held
117,440
-14.6% QoQ
Ownership
5.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 8 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,825,954 across 312 Biotechnology names. XBIO ranks #232 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in XBIO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,750 | 117,440 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $368,339 | 137,440 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $387,364 | 178,509 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $90,903 | 28,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $97,020 | 24,750 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $69,854 | 26,764 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $101,944 | 25,550 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $68,472 | 15,850 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $84,539 | 25,782 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $40,399 | 99,507 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,869 | 143,400 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $61,808 | 115,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $120,997 | 151,058 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $195,235 | 191,407 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $336,977 | 261,223 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $858,724 | 418,890 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $288,090 | 141,221 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $547,504 | 251,149 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $347,208 | 170,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $53,584 | 59,209 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $176,660 | 173,197 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $121,610 | 164,117 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||